Patents
Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664)
07/2003
07/17/2003WO2003057169A2 4-dedimethylamino tetracycline compounds
07/17/2003WO2002005643A3 Biocide compositions and methods and systems employing same
07/17/2003US20030133953 Complexing a biologically active agent with a perturbant to reversibly transform and exposing a membrane or bilayer to the supramolecular complex
07/16/2003EP1326828A1 Beta-amino acid derivatives as integrin receptor antagonists
07/16/2003EP1326822A2 Ketone compounds and compositions for cholesterol management and related uses
07/16/2003CN1430600A 7-and 9-carbamate, urea, thiourea, thiocarbamate and heteroaryl-amino substituted tetracycline compounds
07/15/2003US6593100 Enhanced catalyzed reporter deposition
07/10/2003WO2003055867A1 Biphenylmethyl-thiazolidinediones and analogues and their use as ppar-gamma activators
07/10/2003WO2003055847A1 Carboxylic acid derivative
07/10/2003WO2003055843A1 Agaricoglycerides and analogs
07/10/2003WO2002020464A8 Benzene tricarboxylic acid amides as insulin receptor activators
07/10/2003WO2001098248A3 Hiv integrase inhibitors
07/10/2003US20030130523 Delivers more oxygen to hypoxic and ischemic tissues by reducing the oxygen affinity of hemoglobin in whole blood; substituted phenylacetanilides containing carboxyl group(s)
07/10/2003US20030130519 Reacting 6-aminocarbonylmethyl-4H-2,3-dioxin-4-one compounds with water or an alcohol to form 3-oxopentanedicarboxylic acid monoamides or their monoesters which are useful as medicinals, agrochemicals as raw materials for polyamides.
07/10/2003US20030130349 Inhibitors of alpha 4beta1 mediated cell adhesion
07/10/2003CA2482392A1 Carboxylic acid derivative
07/09/2003EP1325904A1 Novel aliphatic compounds, process for their preparation and their usage
07/09/2003EP1325903A1 2,3-diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage
07/09/2003EP1324979A2 Ionic liquids and their use as solvents
07/09/2003CN1429198A Novel phenyl-proparylether derivatives
07/09/2003CN1429133A Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form
07/08/2003US6590118 Used in treatment of and/or prevention of diabetes, especially non-insulin dependent diabetes (Type 2 diabetes)
07/08/2003US6589970 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
07/03/2003WO2003053915A2 Compounds for the treatment of inflammatory disorders
07/03/2003US20030125329 Treating atherosclerosis and other coronary artery diseases
07/03/2003US20030125328 Treating atherosclerosis and other coronary artery diseases
07/03/2003US20030125315 Providing a focused approach that permits a more rapid screening of probes with potential for association with a particular binding site with a higher likelihood of success; combinatorial chemistry; screening; computer software
07/02/2003EP1322599A2 Hiv integrase inhibitors
07/02/2003EP1322598A1 Nitroso diphenylamine derivatives
07/02/2003EP1322595A2 (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
07/02/2003EP0848700B1 Acylaminosalicylic acid amides and their uses as pesticides
07/01/2003US6586631 Acetoacetarylamide as solidified melt in form which can be used in industry and is easy to handle, which has water content between 3 and 15 percent by weight
07/01/2003US6586598 α, α-dibromo-α-chloro-acetophenones as synthons
07/01/2003US6586559 Polyamide oligomers
07/01/2003US6586475 5-chloro-N-(2-N,N-diethylamino)ethyl)-2- methoxy-4-(1-naphthoylamino)benzamide and prodrugs, used for prevention of neurodegenarative diseases such as Alzheimer's disease
07/01/2003US6586433 Anticholesterol agents; antilipemic agents; cardiovascular disorders
06/2003
06/26/2003WO2003051822A1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar)
06/26/2003WO2003051821A1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar)
06/26/2003WO2003051813A1 Methods of making intermediates from polyhydroxyalkanoates
06/26/2003WO2002060340A3 Method for identifying maxi-k channel blockers
06/26/2003US20030120113 Contacting a nitrile with a monoalkylsulfate to form a monosubstituted amide
06/26/2003US20030119902 Novel aminobenzoephenones
06/26/2003US20030119833 Treating cardiovascular diseases
06/26/2003US20030119721 Electrophilic ketones for the treatment of herpesvirus infections
06/26/2003US20030119664 Hydrogenation catalyst containing phosphite group
06/26/2003CA2470491A1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar)
06/26/2003CA2469302A1 Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar)
06/25/2003EP1320522A2 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins
06/25/2003CN1425364A Detergent composition containing new glycine derivative and its use
06/24/2003US6583319 Cyclic compounds having a cycloalkylene chain
06/24/2003US6583301 Lipids
06/24/2003US6583285 One step reaction of such as 3-(4-methyl-benzoyl)-2-bromo-propyl-dimethylamide and 6-amino-3-picoline
06/24/2003US6583183 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
06/24/2003US6582940 Preparation of crystalline calcium pantothenate; generate saturated solution of calcium pantothenate, stir solution until crystals form, dry suspension
06/24/2003US6582485 Fuel and lubricant additives
06/19/2003WO2003050089A1 Process for the preparation of 4-methyl-7-aminoquinolones
06/19/2003WO2003050078A1 Naphthol derivative and charge control agent comprising the same
06/19/2003WO2003050077A1 Novel stable crystals of substituted phenylpropionic acid derivative and process for producing the same
06/19/2003US20030114528 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
06/19/2003US20030114521 Oxamic acids and derivatives as thyroid receptor ligands
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114454 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/19/2003US20030114435 Benzoic acid derivatives, processes for producing the same and drugs containing the same as the active ingredient
06/19/2003US20030113792 Epoxide polymer surfaces
06/19/2003CA2467511A1 Process for the preparation of 4-methyl-7-aminoquinolones
06/18/2003EP1318977A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
06/18/2003EP1318976A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
06/18/2003EP1318974A2 Resorcinol derivatives
06/17/2003US6579872 Bezamide derivatives for the treatment of diseases mediated by cytokines
06/12/2003WO2003048126A1 Process for the preparation of (2s)-3-[4-({[4-(aminocarbonyl)-1-piperidinyl]carbonyl}oxy) phenyl]2-{((2s)-4-methyl-2-{[2-(2-methylphenoxy)acetyl]amino}pentanoyl)amino[propanoic acid and intermediates therefore
06/12/2003WO2003048109A1 Novel glucagon antagonists
06/12/2003WO2003048108A2 Compounds for treatment of inflammation, diabetes and related disorders
06/12/2003WO2003048101A1 Induction of apoptosis in cancer cells
06/12/2003WO2003048079A2 Method for the arylation of olefins
06/12/2003WO2003047499A2 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting
06/12/2003WO2002017712A3 Disubstituted benzenes as insecticides
06/12/2003US20030109753 Cyan photographic coupler
06/12/2003US20030109749 Processes for the preparation of olefins, unsaturated carboxylic acids and unsaturated nitriles from alkanes
06/12/2003US20030109716 5-acylamino-2-amino-4-substituted-phenol compounds and method of using them
06/12/2003US20030109707 Reacting an imidazolo(1,2)pyridine with aromatic amide
06/12/2003US20030109687 Substituted diaryl or diheteroaryl methans, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
06/12/2003US20030109559 N-(3-amino-2-hydroxy-propyl)substituted alkylamide compounds
06/12/2003US20030109528 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/12/2003US20030109459 Activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
06/12/2003CA2468745A1 Induction of apoptosis in cancer cells
06/11/2003EP1318142A1 T-butoxycarbonylaminoethylamine for the synthesis of pna monomer units, amino acid derivatives, intermediates thereof, and processes for productions of them
06/11/2003EP1318140A1 Novel amide derivatives and medicinal use thereof ugs
06/11/2003EP1318127A2 Improved processes for the preparation of olefins, unsaturated carboxylic acids and unsaturated nitriles from alkanes
06/11/2003EP1317461A1 4-cyclohexyl-1,3,2-oxazaborolidine chiral accessories
06/11/2003EP1317424A2 Polyamine analogues as therapeutic and diagnostic agents
06/11/2003EP1317412A1 Compounds and compositions for delivering active agents
06/11/2003CN1423631A Phenacylamine derivatives, production thereof and pest controllers containing the derivatives
06/11/2003CN1422833A Improved method for preparing olefin, non-mathred carboxyl acid and non-matured nitrile
06/10/2003US6576769 Formed via contacting O-ethyl-L-tyrosine with activating reagent, then contacting with Lewis acid, and quenching with protic solvent
06/10/2003US6576642 Inhibitors of the production of Ig E antibodies, antiallergens
06/10/2003US6576614 Administering methyl ketones or closed hemiketal derivatives of aspartic acid
06/10/2003CA2304713C Biphenyl-5-alkanoic acid derivatives and use thereof
06/10/2003CA2232775C Acyl compounds
06/05/2003WO2003045935A1 Method for alkylating the alpha carbon of the 2-methylbutyrate secondary chain of lovastatin
06/05/2003WO2003045933A2 Preparation and use of gamma-butyrolactones as cross-linking agents
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 157